Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Improving Osimertinib Exposure and Cost-effectiveness Using Pharmacokinetic Boosting With Cobicistat
- Status
- RECRUITING
- Phase
- PHASE4
Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE2
A Study of RC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 Mutation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE2
Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel in Non-squamous NSCLC After First-line Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation
- Status
- TERMINATED
- Phase
- PHASE1
Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)
- Status
- RECRUITING
- Phase
- NA
Impact of Lazertinib Dose Modification on Effectiveness and Safety
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
BR790 in Combination With Anlotinib in Adult Subjects With Advanced Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
IMM60 and Pembrolizumab in Melanoma and NSCLC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Almonertinib Therapy in Patients With Abnormal Liver Function After EGFR-TKI Treatment, or Almonertinib First-line Therapy in Patients With Basic Hepatopathy
- Status
- UNKNOWN
- Phase
- PHASE2
A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
- Status
- UNKNOWN
- Phase
- N/A